This research group focuses on platelet physiology and the analysis of their inflammatory response to biostress, investigating the role of platelet function in the pathophysiological mechanisms through which biostress, whether exogenous (in an infectious context) or endogenous (in a transfusion context), can lead to pathology, with a particular emphasis on pulmonary and cardiovascular systems. Platelets are recognized not only for producing immunomodulatory soluble molecules but also for binding self and non-self molecules involved in various stages of innate or adaptive immunity. Their investigations, combining ex vivo, in vitro, and in vivo approaches, enhance the understanding of platelet responses to biostress.
Specifically, the group examines the inflammatory role of platelets in a transfusion context, aiming to improve and evaluate the processes of platelet concentrate preparation to optimize transfusion outcomes and develop personalized transfusion strategies. Similarly, in an infectious context, they delve into the fundamental mechanisms regulating platelet thrombotic and inflammatory responses during infection to identify new molecular targets and define novel inhibitors of platelets’ anti-infectious inflammatory response. This multidisciplinary approach not only advances our understanding of platelet functions in disease contexts but also paves the way for innovative therapeutic interventions targeting platelet-mediated inflammation.
Per technologias innovativas, ut fabricatio 3D et nanotechnologia, nova materia biocompatibilia et therapiae cellulae-stipatae elaborantur, quae promissionem magnam in cura morborum ostendunt. Praeterea, per simulationes computatorias et analysin datarum magnarum, modelli biologici accuratiores efficiuntur, quod nos ad intellegendum complexitatem vivorum systematum melius ducit.
Collaborationes internationales et transdisciplinares clavis sunt ad successum in hac investigatione, nos adiuvantes ad perspectivas diversas et expertises coniungere, quaestiones scientificas arduas solvendi. Cum finis ultimus sit melioratio curae patientium et qualitatis vitae, investigatio apud SAINBIOSE non solum ad scientiam contribuit, sed etiam ad societatem latius impactum habet, novas vias aperiens ad tractandas pathologias hodiernas ac futuras.
In hoc itinere scientifico, semper novis quaestionibus occurremus, quae nos ad limina cognitionis nostrae pellunt, inspirantes nos ad persequendum quod adhuc incognitum est.
Project Leader : Votre texte ici
Researchers involved :
Lab scientists involved:
NAME Surname + team/group
Student involved :
NAME Surname + team/group
Per technologias innovativas, ut fabricatio 3D et nanotechnologia, nova materia biocompatibilia et therapiae cellulae-stipatae elaborantur, quae promissionem magnam in cura morborum ostendunt. Praeterea, per simulationes computatorias et analysin datarum magnarum, modelli biologici accuratiores efficiuntur, quod nos ad intellegendum complexitatem vivorum systematum melius ducit.
Collaborationes internationales et transdisciplinares clavis sunt ad successum in hac investigatione, nos adiuvantes ad perspectivas diversas et expertises coniungere, quaestiones scientificas arduas solvendi. Cum finis ultimus sit melioratio curae patientium et qualitatis vitae, investigatio apud SAINBIOSE non solum ad scientiam contribuit, sed etiam ad societatem latius impactum habet, novas vias aperiens ad tractandas pathologias hodiernas ac futuras.
In hoc itinere scientifico, semper novis quaestionibus occurremus, quae nos ad limina cognitionis nostrae pellunt, inspirantes nos ad persequendum quod adhuc incognitum est.
Project Leader : Votre texte ici
PI involved : NAME Surname + team/group
ITA involved: NAME Surname + team/group
Student involved : NAME Surname + team/group